$265.39 +1.64 (%) Actavis PLC - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Baidu, Alibaba Among Top World Stocks Building Bases

    IBD | Dec. 18, 2014 | 18:09PM EST
  2. Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside

    Benzinga | Dec. 18, 2014 | 16:15PM EST
  3. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  4. Great Stocks: Valeant Pharmaceuticals Near Buy Point

    IBD | Dec. 16, 2014 | 18:11PM EST
  5. Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition

    Benzinga | Dec. 16, 2014 | 07:32AM EST
  6. The Gurus to Follow Based on Sector - Part 2

    GuruFocus | Dec. 9, 2014 | 16:20PM EST
  7. Stock Market Today: Wall Street Drops; Conn's Down 40%

    IBD | Dec. 9, 2014 | 11:55AM EST
  8. Valeant Abandoning its Growth by Acquisition Strategy -Reuters

    Benzinga | Dec. 9, 2014 | 05:13AM EST
  9. Top Global Stocks: Jazz, Actavis In IBD's World List

    IBD | Dec. 8, 2014 | 18:31PM EST
  10. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  11. Bank Of America: How To Profit From An Aging Population

    Benzinga | Dec. 5, 2014 | 10:46AM EST
  12. Great Stocks In 2014: Airline, Video Game, Drugs Lead

    IBD | Dec. 4, 2014 | 18:53PM EST
  13. Great Stocks: Mallinckrodt Buys Raise Profit Margins

    IBD | Dec. 4, 2014 | 18:20PM EST
  14. Dodge & Cox's Top New Buys of Q3

    GuruFocus | Dec. 4, 2014 | 12:26PM EST
  15. Top Funds Gobble Up Tech And Medical Stocks

    IBD | Dec. 2, 2014 | 18:19PM EST
  16. U.S. Stock Mutual Funds Led Advance In November

    IBD | Dec. 2, 2014 | 18:19PM EST
  17. Larry Robbins Lives Up to Reputation for Investing in Healthcare Sector

    GuruFocus | Dec. 1, 2014 | 16:59PM EST
  18. UPDATE: Actavis Launches Generic Version of Intuniv

    Benzinga | Dec. 1, 2014 | 16:06PM EST
  19. Valeant Rises After Allergan Snub; Zeltiq In Buy Area

    IBD | Nov. 19, 2014 | 18:14PM EST
  20. Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy

    IBD | Nov. 19, 2014 | 17:35PM EST
  21. Mallinckrodt Earnings Beat But No New Guidance

    IBD | Nov. 19, 2014 | 11:42AM EST
  22. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  23. Nasdaq, S&P, Dow Hit Highs

    IBD | Nov. 18, 2014 | 18:50PM EST
  24. Actavis'

    IBD | Nov. 18, 2014 | 18:42PM EST
  25. Vipshop, Jack in the Box Rise In After-Hours Trading

    IBD | Nov. 18, 2014 | 17:04PM EST
  26. Dow, S&P 500 Add To Gains Following Encouraging International News

    Benzinga | Nov. 18, 2014 | 17:02PM EST
  27. Stocks Hit New Milestones; BitAuto Rebounds

    IBD | Nov. 18, 2014 | 16:17PM EST
  28. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  29. Stock Movers: Why 4 Big Drug Stocks Are Rising Today

    IBD | Nov. 18, 2014 | 14:38PM EST
  30. Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders

    Benzinga | Nov. 18, 2014 | 14:17PM EST
  31. Stocks Hold Near Fresh Milestones; Actavis Hits New High

    IBD | Nov. 18, 2014 | 13:33PM EST
  32. Ackman Pledges Support For Actavis Bid On Allergan

    Benzinga | Nov. 18, 2014 | 13:10PM EST
  33. Is Bill Ackman Back?

    Benzinga | Nov. 18, 2014 | 10:56AM EST
  34. Benzinga's Volume Movers

    Benzinga | Nov. 18, 2014 | 10:36AM EST
  35. Citi Raises Price Target On Actavis

    Benzinga | Nov. 18, 2014 | 08:44AM EST
  36. #PreMarket Primer: Tuesday, November 18: Abe To Delay Sales Tax Increase In Japan

    Benzinga | Nov. 18, 2014 | 07:23AM EST
  37. Here Are Some Big Caps Poised To Make Gains

    IBD | Nov. 17, 2014 | 18:45PM EST
  38. Allergan Takes A Better Offer

    IBD | Nov. 17, 2014 | 18:39PM EST
  39. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  40. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  41. Actavis' $66 Bil Offer Steals Allergan From Valeant

    IBD | Nov. 17, 2014 | 17:31PM EST
  42. U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts

    Benzinga | Nov. 17, 2014 | 16:46PM EST
  43. Stocks End Mixed As Allergan Jumps On Actavis Deal

    IBD | Nov. 17, 2014 | 16:16PM EST
  44. Stocks Mixed In Afternoon; Allergan Jumps To New High

    IBD | Nov. 17, 2014 | 15:13PM EST
  45. Mid-Day Market Update: Allergan Jumps On Actavis Bid; Denbury Resources Shares Slip

    Benzinga | Nov. 17, 2014 | 13:23PM EST
  46. Top Performing Industries For November 17, 2014

    Benzinga | Nov. 17, 2014 | 10:46AM EST
  47. Mid-Morning Market Update: Markets Edge Lower; Halliburton To Acquire Baker Hughes For $34.6 Billion

    Benzinga | Nov. 17, 2014 | 10:42AM EST
  48. Benzinga's Volume Movers

    Benzinga | Nov. 17, 2014 | 10:29AM EST
  49. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 17, 2014 | 10:18AM EST
  50. Actavis Nabs Allergan For $66 Billion; Valeant Folds

    IBD | Nov. 17, 2014 | 10:17AM EST
Trading Center